Latest Home hemodialysis Stories

Glen Lerner Injury Attorneys is Now Accepting Dialysis Related Heart Attack Claims for Review

2013-03-07 23:00:15

The national medical injury law offices of Glen Lerner Injury Attorneys announced that they are now accepting dialysis related heart attack claims for review associated with NaturaLyte Liquid and GranuFlo Dry Acid Concentrate. Family members who believe they lost a family member to a wrongful death, OR people who believe they experienced a heart related health complication after receiving a dialysis treatment using one of these dialysis products are encouraged to call 1 (800) GET-GLEN for...

Dialysis Patient Organizations Form Groundbreaking Partnership to Empower and Educate Patients

2013-03-06 16:26:16

Dialysis Patient Citizens, DPC Education Center and the Shad Ireland Foundation Combine Efforts to Improve Patient Quality of Life WASHINGTON, March 6, 2013 /PRNewswire-USNewswire/ -- Dialysis Patient Citizens (DPC), the DPC Education Center and the Shad Ireland Foundation (SIF) are proud to announce a new partnership effort aimed at empowering dialysis patients and improving patient quality of life. Under this new partnership, the organizations will collaborate on innovative and...

DSI Renal Expands Georgia Presence with Conyers and Kennesaw Dialysis Clinics

2013-02-25 12:25:25

- Growing dialysis company offers a personalized experience for patients and physician partners CONYERS and KENNESAW, Ga., Feb. 25, 2013 /PRNewswire/ -- DSI Renal, a leading provider of dialysis services for patients suffering from chronic kidney failure, has expanded its presence in Georgia with the opening of two new, state-of-the-art dialysis centers. DSI Conyers Dialysis and DSI Kennesaw Home Dialysis offer exceptional medical care, upscale patient amenities and convenient...

NxStage Announces CE Mark Approval, First Clinical Use of its Single Needle for Dialysis Patients

2013-02-25 08:28:43

Elegant Solution Enhances Company's Recent Nocturnal Clearance in Europe LAWRENCE, Mass., Feb. 25, 2013 /PRNewswire/ -- NxStage® Medical, Inc. (Nasdaq: NXTM), a leading manufacturer of innovative dialysis products, today announced its single needle technology, OneSite(TM), has received CE Mark approval. In addition, initial patient experiences using this new product have demonstrated its benefits for dialysis patients. (Logo: http://photos.prnewswire.com/prnh/20110503/MM94799LOGO)...

NxStage Announces CE Mark Approval for New High Flow Capabilities with System One

2013-02-21 08:31:12

LAWRENCE, Mass., Feb. 21, 2013 /PRNewswire/ -- NxStage® Medical, Inc. (Nasdaq: NXTM), a leading manufacturer of innovative dialysis products, today announced CE Mark approval for new high flow capabilities with the NxStage System One(TM). With this approval, the Company expects to bring this advancement to customers in countries that recognize the CE Mark approval process later this year. (Logo: http://photos.prnewswire.com/prnh/20110503/MM94799LOGO ) The new high flow...

NxStage Announces CE Mark Approval for Nocturnal Home Hemodialysis

2013-02-19 08:33:00

LAWRENCE, Mass., Feb. 19, 2013 /PRNewswire/ -- NxStage® Medical, Inc. (Nasdaq: NXTM), a leading manufacturer of innovative dialysis products, today announced CE Mark approval for nocturnal home hemodialysis with the NxStage System One(TM). With CE Mark approval, the NxStage System One is continuing its leadership in home hemodialysis technology. NxStage expects to begin marketing the System One for nocturnal dialysis in countries that recognize the CE Mark approval process in the...

Technique That Removes Additional Toxins Prolongs Dialysis Patients' Lives

2013-02-15 15:20:59

Hemodiafiltration reduces risk of dying over the course of a 3-year study Highlights" -A technique that removes additional toxins during dialysis decreased kidney failure patients' risk of dying from any cause by 30% over three years. -The technique also reduced patients' risk of dying from heart-related causes or infections. 15% to 25% of dialysis patients die annually. A technique that removes additional toxins during dialysis may prolong kidney failure patients' lives,...

NxStage Initiates 2013 'Call to Action' Campaign with Launch of Hemodialysis At Home: A Better Way For a Better Life

2013-02-14 08:29:15

LAWRENCE, Mass., Feb. 14, 2013 /PRNewswire/ -- NxStage Medical, Inc. (Nasdaq: NXTM) is reinforcing its efforts with patients, care partners and renal professionals to increase awareness about the benefits of home hemodialysis (HHD) and advocate for reimbursement policy changes with the Centers for Medicare and Medicaid Services (CMS) specifically as it relates to reimbursement for HHD training. (Logo: http://photos.prnewswire.com/prnh/20110503/MM94799LOGO ) Today, the Company...

Trillium Health Partners Implements CellTrak™ Mobile Solution for Infusion Nurses

2013-02-12 23:03:53

Renal Program implements mobile solution for staff safety for Home Dialysis Schaumburg, IL and Mississauga, ON (PRWEB) February 12, 2013 Trillium Health Partners is a leading hospital with an outstanding record of performance, fiscal responsibility and quality patient care. The hospital encompasses three main sites – Credit Valley Hospital, Mississauga Hospital, and Queensway Health Centre – offering the full range of acute care hospital services, as well as a variety of...

Kidney Disease Patients At Risk With Frequent Dialysis

2013-02-08 11:42:19

Frequent treatments improve health but increase risks for certain complications Highlights: -Compared with standard dialysis, frequent dialysis can cause complications related to repeated access to the blood. -The findings provide valuable information for dialysis patients and their physicians. -Approximately 2 million patients in the world receive dialysis treatments. Compared with standard dialysis, frequent dialysis can cause complications related to repeated access to the...